unknown
Stage
2
Investors
About
Emulsi Biotech develops NanoLIPID™, a green enzyme technology platform that creates self-assembling lipid mixtures for drug delivery, nutraceuticals, and bioactive compounds.
Explore Emulsi Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.